These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3722363)

  • 1. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jul; 24(1):157-60. PubMed ID: 3722363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.
    Douglas RG; Markoff LJ; Murphy BR; Chanock RM; Betts RF; Hayden FG; Levine MM; Van Blerk GA; Sotman SB; Nalin DR
    Infect Immun; 1979 Oct; 26(1):274-9. PubMed ID: 500204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.
    Wagner DK; Clements ML; Reimer CB; Snyder M; Nelson DL; Murphy BR
    J Clin Microbiol; 1987 Mar; 25(3):559-62. PubMed ID: 3571460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ; Belshe RB; Munn NJ
    J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
    J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
    Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR
    Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.
    Burlington DB; Clements ML; Meiklejohn G; Phelan M; Murphy BR
    Infect Immun; 1983 Aug; 41(2):540-5. PubMed ID: 6874068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.
    Murphy BR; Phelan MA; Nelson DL; Yarchoan R; Tierney EL; Alling DW; Chanock RM
    J Clin Microbiol; 1981 Mar; 13(3):554-60. PubMed ID: 7240388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.
    Wright PF; Murphy BR; Kervina M; Lawrence EM; Phelan MA; Karzon DT
    Infect Immun; 1983 Jun; 40(3):1092-5. PubMed ID: 6852914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.
    Gorse GJ; Belshe RB; Munn NJ
    J Clin Microbiol; 1988 May; 26(5):911-8. PubMed ID: 3384914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.